MXCT logo

MXCT
MaxCyte Inc

443
Mkt Cap
$107.12M
Volume
1.19M
52W High
$2.40
52W Low
$0.6434
PE Ratio
-2.94
MXCT Fundamentals
Price
$1.08
Prev Close
$1.00
Open
$1.00
50D MA
$0.8504
Beta
1.39
Avg. Volume
755,825.07
EPS (Annual)
-$0.4194
P/B
0.69
Rev/Employee
$362,923.08
$79.86
Loading...
Loading...
News
all
press releases
Here's Why MaxCyte (MXCT) is Becoming a High-Conviction Bet for Investors
Here's Why MaxCyte (MXCT) is Becoming a High-Conviction Bet for Investors...
News Placeholder
More News
News Placeholder
Cisco, Alibaba And 3 Stocks To Watch Heading Into Wednesday
US stock futures mixed, Cisco and MaxCyte report positive earnings, Alibaba and Vishay to release results.read more...
News Placeholder
MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates
MaxCyte (MXCT) delivered earnings and revenue surprises of +57.90% and +31.31%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
News Placeholder
MaxCyte (MXCT) Expected to Announce Quarterly Earnings on Tuesday
MaxCyte (NASDAQ:MXCT) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 12. (View Earnings Report at...
News Placeholder
MaxCyte, Inc. (NASDAQ:MXCT) Receives Consensus Rating of "Hold" from Brokerages
MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) has earned a consensus recommendation of "Hold" from the five brokerages that are covering the stock, MarketBeat reports. One equities research analyst...
News Placeholder
Wall Street Zen Downgrades MaxCyte (NASDAQ:MXCT) to Sell
Wall Street Zen lowered MaxCyte from a "hold" rating to a "sell" rating in a report on Saturday...
News Placeholder
MaxCyte (NASDAQ:MXCT) Upgraded by Wall Street Zen to Hold Rating
Wall Street Zen upgraded shares of MaxCyte from a "sell" rating to a "hold" rating in a research note on Tuesday...
News Placeholder
MaxCyte, Inc. (NASDAQ:MXCT) Receives Average Rating of "Hold" from Brokerages
MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) has been assigned an average rating of "Hold" from the five ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and two...
News Placeholder
Craig Hallum Issues Pessimistic Forecast for MaxCyte (NASDAQ:MXCT) Stock Price
Craig Hallum reduced their target price on MaxCyte from $7.00 to $5.00 and set a "buy" rating for the company in a research note on Wednesday...
News Placeholder
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
<
1
2
...
>

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available